Naoki Inui (N Inui)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Pulmonary Fibrosis

Clinical Evaluation

Epidermal Growth Factor Receptor

Top Venues

Respirology (Carlton, Vic.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Hyogo Naoi, Yuzo Suzuki, Asuka Miyagi, Ryo Horiguchi, Yuya Aono, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Shinji Mii, Masatoshi Ichihara, Masahide Takahashi, Takafumi Suda
CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling. Journal of immunology (Baltimore, Md. : 1950) 212 (7) (2024)
Hirofumi Watanabe, Yusuke Inoue, Masato Karayama, Shusuke Yazawa, Yasutaka Mochizuka, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Kazuya Shinmura, Naoki Inui, Takafumi Suda
Characterization of BRAF Thr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling. JCO precision oncology 8 (2024)
Naoki Inui, Takahito Suzuki, Kazuki Tanaka, Masato Karayama, Yusuke Inoue, Kazutaka Mori, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Shun Matsuura, Koji Nishimoto, Takashi Matsui, Kazuhiro Asada, Dai Hashimoto, Masato Fujii, Mitsuru Niwa, Masahiro Uehara, Hiroyuki Matsuda, Keigo Koda, Masaki Ikeda, Nao Inami, Yutaro Tamiya, Masato Kato, Hideki Nakano, Yasuaki Mino, Noriyuki Enomoto, Takafumi Suda
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Naoki Inui, Takahito Suzuki, Kazuki Tanaka, Masato Karayama, Yusuke Inoue, Kazutaka Mori, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Shun Matsuura, Koji Nishimoto, Takashi Matsui, Kazuhiro Asada, Dai Hashimoto, Masato Fujii, Mitsuru Niwa, Masahiro Uehara, Hiroyuki Matsuda, Keigo Koda, Masaki Ikeda, Nao Inami, Yutaro Tamiya, Masato Kato, Hideki Nakano, Yasuaki Mino, Noriyuki Enomoto, Takafumi Suda
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hyogo Naoi, Yuzo Suzuki, Asuka Miyagi, Ryo Horiguchi, Yuya Aono, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Shinji Mii, Masatoshi Ichihara, Masahide Takahashi, Takafumi Suda
CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling. Journal of immunology (Baltimore, Md. : 1950) (2024)
Naoki Inui, Takahito Suzuki, Kazuki Tanaka, Masato Karayama, Yusuke Inoue, Kazutaka Mori, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Shun Matsuura, Koji Nishimoto, Takashi Matsui, Kazuhiro Asada, Dai Hashimoto, Masato Fujii, Mitsuru Niwa, Masahiro Uehara, Hiroyuki Matsuda, Keigo Koda, Masaki Ikeda, Nao Inami, Yutaro Tamiya, Masato Kato, Hideki Nakano, Yasuaki Mino, Noriyuki Enomoto, Takafumi Suda
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Hirofumi Watanabe, Yusuke Inoue, Masato Karayama, Shusuke Yazawa, Yasutaka Mochizuka, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Kazuya Shinmura, Naoki Inui, Takafumi Suda
Characterization of BRAF Thr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling. JCO precision oncology 8 (2024)
Naoki Inui, Takahito Suzuki, Kazuki Tanaka, Masato Karayama, Yusuke Inoue, Kazutaka Mori, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Shun Matsuura, Koji Nishimoto, Takashi Matsui, Kazuhiro Asada, Dai Hashimoto, Masato Fujii, Mitsuru Niwa, Masahiro Uehara, Hiroyuki Matsuda, Keigo Koda, Masaki Ikeda, Nao Inami, Yutaro Tamiya, Masato Kato, Hideki Nakano, Yasuaki Mino, Noriyuki Enomoto, Takafumi Suda
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Takahito Suzuki, Masato Karayama, Yoichiro Aoshima, Kazutaka Mori, Nobuko Yoshizawa, Shintaro Ichikawa, Shinpei Kato, Koshi Yokomura, Masato Kono, Dai Hashimoto, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Satoshi Goshima, Naoki Inui, Takafumi Suda
Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias. Respirology (Carlton, Vic.) (2023)
Yasutaka Mochizuka, Yuzo Suzuki, Masato Kono, Hirotsugu Hasegawa, Dai Hashimoto, Koshi Yokomura, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.) (2023)
Naoki Inui, Yukihiro Toi, Yasuto Yoneshima, Masahiro Morise, Akito Hata, Kaoru Kubota, Toshiaki Saeki, Tomohide Tamura
Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase. Advances in therapy (2023)
Akito Hata, Isamu Okamoto, Naoki Inui, Morihito Okada, Masahiro Morise, Kohei Akiyoshi, Masayuki Takeda, Yasutaka Watanabe, Shunichi Sugawara, Naofumi Shinagawa, Kaoru Kubota, Toshiaki Saeki, Tomohide Tamura
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Yuzo Suzuki, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koushi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy. Respirology (Carlton, Vic.) 26 (2) (2020)
Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Takafumi Suda
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial. Respirology (Carlton, Vic.) 26 (4) (2020)
Naoki Katayama, Keiichi Odagiri, Akio Hakamata, Chiaki Kamiya, Shinya Uchida, Shimako Tanaka, Naoki Inui, Noriyuki Namiki, Koichiro Tatsumi, Hiroshi Watanabe
Clinical evaluation of drug-drug interactions between the cytochrome P450 substrates selexipag and clopidogrel in Japanese volunteers. British journal of clinical pharmacology 87 (4) (2020)
Yoichiro Aoshima, Masato Karayama, Naoki Inui, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Masashi Mikamo, Shun Matsuura, Hideki Kusagaya, Yusuke Kaida, Tomohiro Uto, Dai Hashimoto, Takashi Matsui, Kazuhiro Asada, Takafumi Suda
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Investigational new drugs 39 (1) (2020)
Norimichi Akiyama, Hironao Hozumi, Takuya Isayama, Jun Okada, Katsunori Sugiura, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Takafumi Suda
Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.) 25 (7) (2019)
Kazuki Tanaka, Naoki Inui, Masato Karayama, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Hideki Kusagaya, Shun Matsuura, Tomohiro Uto, Dai Hashimoto, Takashi Matsui, Kazuhiro Asada, Takafumi Suda
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting. Cancer chemotherapy and pharmacology 84 (1) (2019)
Norimichi Akiyama, Masato Karayama, Naoki Inui, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Nao Inami, Shun Matsuura, Yusuke Kaida, Tomohiro Uto, Takashi Matsui, Kazuhiro Asada, Hiroyuki Matsuda, Masato Fujii, Mikio Toyoshima, Takafumi Suda
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma. Investigational new drugs 37 (3) (2019)
Koji Nishimoto, Masato Karayama, Naoki Inui, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Nao Inami, Shun Matsuura, Yusuke Kaida, Takashi Matsui, Kazuhiro Asada, Hiroyuki Matsuda, Masato Fujii, Mikio Toyoshima, Shiro Imokawa, Takafumi Suda
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study. Medical oncology (Northwood, London, England) 35 (7) (2018)
Masato Karayama, Naoki Inui, Kazuki Tanaka, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Takafumi Suda
Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis. Medical oncology (Northwood, London, England) 35 (11) (2018)
M Karayama, Naoki Inui, K Mori, M Kono, H Hozumi, Yuzo Suzuki, K Furuhashi, D Hashimoto, N Enomoto, T Fujisawa, Y Nakamura, H Watanabe, T Suda
Respiratory impedance is correlated with airway narrowing in asthma using three-dimensional computed tomography. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 48 (3) (2018)
Shinpei Kato, Naoki Inui, Akio Hakamata, Yuzo Suzuki, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Hiroshi Watanabe, Takafumi Suda
Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis. Respiratory research 19 (1) (2018)